Latest Announcements

Jonjua Overseas Ltd has released its annual report for FY 2025-2026, showing a significant increase in total income and profit after tax. The company has also announced a bonus share issue and reappointment of a director.

Dr. Lal Path Labs Ltd. has informed the Exchange about the Transcript of Q1 & FY27 Earnings Conference Call. The company's revenue for Q1 FY27 was Rs. 798 crore, registering a year-on-year growth of 19.1%. The revenue growth is mainly driven by Patient volumes and sample volumes.

Indegene Limited has announced its financial results for the quarter ended June 30, 2026, with revenue up 39.7% YoY and PAT up 45.9% QoQ.

Epigral Limited has released the transcript of its Q1 FY27 earnings conference call, discussing its performance in a challenging operating environment. The company reported a 15% revenue growth and 25% EBITDA margin, driven by increased sales volume and improved realization. Epigral also announced a strategic capex plan for two new projects, including a 125,000 tons per annum Epoxy Resin & Formulations plant and a multipurpose plant.

Indegene Ltd announced its financial results for the quarter ended June 30, 2026, with revenue up 39.7% YoY and PAT up 45.9% QoQ. The company also crossed the 100-milestone in active clients and expanded its customer base in the $10M+ range.

Best Agrolife Ltd reported a 4% YoY growth in revenue to ₹396 crore in Q1 FY27, with a 32% YoY increase in gross profit to ₹146 crore and a 70% YoY increase in EBITDA to ₹78 crore. PAT increased to ₹41 crore, representing a 104% YoY growth.

Tata Steel Ltd reported Consolidated EBITDA of Rs 9,370 crores for the quarter ended June 30, 2026, with a 25% YoY improvement despite a volatile operating environment. The company's India operations delivered strong results, with EBITDA per ton improving by Rs 3,255 per ton QoQ to Rs 19,162 per ton.

Tata Steel Ltd reported consolidated EBITDA of Rs 9,370 crores for Q1FY2027, with a 25% YoY improvement despite a volatile operating environment. The company's India operations delivered a strong performance, with domestic deliveries growing 11% YoY to 4.85 million tons. The Board approved a 4.8 MTPA expansion at Neelachal Ispat Nigam Limited, central to the company's strategy of deepening its presence in high-margin and branded long products.

Tata Steel Limited has informed the Exchange about Investor Presentation, submitting a press release and investor presentation to be made to Analysts/Investors on the Financial Results of Tata Steel Limited for the quarter ended June 30, 2026. The company reports Consolidated EBITDA of Rs 9,370 crores for the quarter, with India revenues of Rs 36,989 crores and EBITDA of Rs 9,908 crores, translating to an EBITDA margin of 27%. The company has spent Rs 3,579 crores on capital expenditure during the quarter and has a net debt of Rs 84,173 crores and net debt to EBITDA of 2.3x.

Aeroflex Industries Ltd reported its highest quarterly performance ever, with a 72.4% year-on-year increase in consolidated revenue to INR145.97 crores. The company's EBITDA and profit after tax also saw significant growth, with EBITDA up 116% and profit after tax up 162% year-on-year. The company's cash profit grew by over 100% and the cash profit margin improved by 278 basis points to 18.25%. The company's exports grew by 43% year-on-year.

Vivid Global Industries Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 to consider and approve unaudited financial results for the quarter ended 30th June, 2026, along with limited review report, and other items.

Best Agrolife Ltd reported a 4% YoY growth in revenue to ₹396 crore, with a 32% YoY increase in gross profit to ₹146 crore. EBITDA margin expanded to 20% from 12% in the corresponding quarter last year. Profit after tax increased to ₹41 crore, representing a 104% YoY growth.

Tata Steel Limited has reported its consolidated EBITDA of Rs 9,370 crores for the quarter ended June 30, 2026, with a 25% YoY improvement despite a volatile operating environment. The company has also announced a 4.8 MTPA expansion at Neelachal Ispat Nigam Limited.

Aarti Industries Ltd reported a strong Q1 FY27 with 79% YoY and 13% QoQ EBITDA growth, driven by an optimised product mix, inventory, and forex gains. The Company delivered a healthy start to FY27 despite a challenging global operating environment.

ICRA Ltd, a credit rating agency, has released its Q1 FY2027 investor presentation, highlighting its strong quarterly performance, driven by growth in ratings and sustained momentum in risk & analytics. The company has acquired the remaining stakes in D2K Technologies India Private Limited and Fintellix India Private Limited, making them wholly-owned subsidiaries. ICRA's revenue and profit after tax have increased, with a growth of 31.2% and 32.0% respectively. The company has also provided its macro outlook for FY2027, with a real GDP growth of 6.7% and a fiscal deficit of -0.9%. However, the company has warned of downside risks to India's growth outlook in FY2027, including the West Asia conflict and weak monsoon.

Gravita India Ltd has announced the earnings conference call transcript for Q1 FY27, showcasing a 4% growth in volumes, 42% in revenue, 29% in EBITDA, and 14% in PAT on a year-on-year basis.

Aarti Industries Limited reported Q1 FY27 unaudited financial results, with revenue from operations at ₹2627 crore, EBITDA at ₹385 crore, and PAT at ₹155 crore, registering 41% YoY and 260% YoY growth respectively. The company reaffirmed its long-term growth outlook and continued to make progress on its expansion and digital transformation initiatives.

Best Agrolife Limited has announced its financial results for the quarter ended June 30, 2026, with revenue from operations growing 4% YoY to ₹396 crore, gross profit increasing 32% YoY to ₹146 crore, and profit after tax (PAT) rising 104% YoY to ₹41 crore.

Alivus Life Sciences Ltd has released its Q1 FY 2026-27 investor presentation, highlighting a positive start to the year with strong execution and accelerating traction in the non-GPL business. The company expects revenue growth of 10% - 12% in FY27, while sustaining EBITDA margins in the 30%–32% range.

Alivus Life Sciences Limited has reported Q1 FY27 results, with revenue growth of 6.4% YoY, driven by strong momentum in the non-GPL business, and EBITDA margins of 36.6%. The company expects revenue growth of 10-12% in FY27 and sustaining EBITDA margins in the 30-32% range.